SEC Form D private-offering filing

NBO Pharma Inc.

Name: NBO Pharma Inc. - new SEC Form D private-offering filing, Bedford, NY
Published: 2026-01-22

A new SEC Form D private-offering notice from Bedford, NY, a $7,640,217 filer-stated offering target in Biotech. The source filing is one click away.

NBO Pharma Inc. site↗ Verified via SEC Form D

Clinical-stage pharmaceutical company developing an intranasal octreotide formulation to treat Idiopathic Intracranial Hypertension, in Phase 2 trials with US and EU orphan drug designations.

Filed 2026-01-22Filed to raise $7,640,217First money in 2025-06-12Raised so far $7,640,217HQ (as filed) Bedford, NYSector Biotech ✓Stage (inferred) EarlyCall status Late filing

Source linked the Form D on EDGAR↗Website verified nbopharma.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.